A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)

clinical trial

A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053) is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT01120600

P6099clinical trial phasephase III clinical trialQ42824827
P582end time2013-07-22
P4135maximum age95
P1050medical conditionosteoporosisQ165328
P2899minimum age40
P1132number of participants294
P4844research interventioncalcium carbonateQ23767
calcium oxalateQ412399
(5R)-24,25-Dihydroxyvitamin DQ27161510
P580start time2010-06-09
P8363study typeinterventional studyQ78089383
P1476titleA Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) in the Treatment of Men With Osteoporosis Treated With Vitamin D and Calcium